Tenon Medical, Inc. ( NASDAQ: TNON) Q3 2024 Earnings Conference Call November 13, 2024 4:30 PM ET Greetings, and welcome to the Tenon Medical Third Quarter 2024 Financial Results and Corporate Update ...
Presented positive interim data for 4D-150 in wet age-related macular degeneration (wet AMD) from PRISM Phase 1/2 clinical trial highlighting robust and durable clinical activity across diverse ...
is a biopharmaceutical company specializing in the innovative delivery of therapies to the back of the eye through the suprachoroidal space ... of the ODYSSEY Phase 2b trial for their drug CLS-AX in ...